Lipidic Aminoglycoside Derivatives: A New Class of Immunomodulators Inducing a Potent Innate Immune Stimulation

Development of simple and fully characterized immunomodulatory molecules is an active area of research to enhance current immunotherapies. Monophosphoryl lipid A (MPL), a nontoxic lipidic derivative from bacteria, is the first and currently only adjuvant approved in humans. However, its capacity to...

Descripción completa

Detalles Bibliográficos
Autores principales: Colombani, Thibault, Haudebourg, Thomas, Decossas, Marion, Lambert, Olivier, Ada Da Silva, Grace, Altare, Frederic, Pitard, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Full Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702646/
https://www.ncbi.nlm.nih.gov/pubmed/31453059
http://dx.doi.org/10.1002/advs.201900288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702646/
https://www.ncbi.nlm.nih.gov/pubmed/31453059
http://dx.doi.org/10.1002/advs.201900288

Ejemplares similares